Atrial fibrillation and obesity an association of increasing importance.
Dagres
Nikolaos
N
Anastasiou-Nana
Maria
M
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D015992:Body Mass Index; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods; D015897:Comorbidity; D004562:Electrocardiography; D005260:Female; D006801:Humans; D015994:Incidence; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate
D000889:Anti-Arrhythmia Agents